Biophytis to Host Virtual KOL Event on Sarconeos (BIO101) on its Lead Projects in COVID-19 and Sarcopenia
PARIS and CAMBRIDGE, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) — Biophytis SA (NasdaqCM: BPTS, Euronext…
PARIS and CAMBRIDGE, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) — Biophytis SA (NasdaqCM: BPTS, Euronext…
Geneva, Switzerland, October 6, 2021 – Addex Therapeutics (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company…
Encouraging preclinical data support continued advancement of SZN-1326 towards first in human clinical studies in…
IRVINE, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a…
MALVERN, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical…
FOSTER CITY, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
–Management to host conference call and webcast on October 12th at 4:30 p.m. ET- ZUG,…
Androgen Receptor (AR) inhibition is an important therapeutic approach for the treatment of Castration-Resistant Prostate…
SANTA CLARA, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
DUBLIN, Ireland and TREVOSE, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc (NASDAQ: SBBP) (the…
Prospective joint venture will accelerate precision medicine in Europe by harnessing innovations in high-throughput drug…
KEEGO HARBOR, Mich., Oct. 05, 2021 (GLOBE NEWSWIRE) — Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW)…
Levitee Labs achieves August 2021 revenues of $893,863 Levitee Clinics & Pharmacies achieves August 2021…
Dr. Periman Joins Chairman Joseph Tauber as Advisory Board’s Second Member SAN DIEGO, Oct. 05,…
CAMBRIDGE, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage…
LAWRENCEVILLE, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage development…
MENLO PARK, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical…
Scopus to present on the recent launch of Duet Therapeutics, its wholly-owned subsidiary focused on immuno-oncology…
BOSTON, Oct. 05, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare pediatric…
Genovac Becomes the First Contract Research Organization (CRO) to Leverage the Beacon System for Both…